Cancerous cells have antigens. Monoclonal antibodies can be designed to bind specifically with these antigens. When injected into a person's body, the monoclonal antibodies will bind with these cancer cells and clump them together. This makes it easier to identify a cancerous tumour, which can then be treated or removed.